These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9565633)

  • 41. An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR with different kinetic stability.
    Gyotoku T; Fukui Y; Sasazuki T
    Eur J Immunol; 1998 Dec; 28(12):4050-61. PubMed ID: 9862341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking.
    Lehmann PV; Cardinaux F; Appella E; Muller S; Falcioni F; Adorini L; Nagy ZA
    Eur J Immunol; 1989 Jun; 19(6):1071-7. PubMed ID: 2787751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
    Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.
    Mohan JF; Unanue ER
    Mol Immunol; 2013 Sep; 55(2):166-8. PubMed ID: 23200226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
    Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
    Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope.
    Lang Y; Forquet F; Speck E; Blum J; Delovitch TL
    Diabetes; 1996 Dec; 45(12):1711-9. PubMed ID: 8922356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.
    Larsen SL; Pedersen LO; Buus S; Stryhn A
    J Exp Med; 1996 Jul; 184(1):183-9. PubMed ID: 8691132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unconventional recognition of peptides by T cells and the implications for autoimmunity.
    Mohan JF; Unanue ER
    Nat Rev Immunol; 2012 Oct; 12(10):721-8. PubMed ID: 22955843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.
    Lich JD; Elliott JF; Blum JS
    J Exp Med; 2000 May; 191(9):1513-24. PubMed ID: 10790426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
    Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
    Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymic T-cell tolerance of neuroendocrine functions: physiology and pathophysiology.
    Geenen V; Kecha O; Brilot F; Hansenne I; Renard C; Martens H
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):179-88. PubMed ID: 11292253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing.
    Brett SJ; Cease KB; Berzofsky JA
    J Exp Med; 1988 Jul; 168(1):357-73. PubMed ID: 2456373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance.
    Ramsdell F; Fowlkes BJ
    Science; 1990 Jun; 248(4961):1342-8. PubMed ID: 1972593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules.
    Casten LA; Kaumaya P; Pierce SK
    J Exp Med; 1988 Jul; 168(1):171-80. PubMed ID: 2840479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.